Federal Register / Vol. 85, No. 234 / Friday, December 4, 2020 / Notices 78345 

policies and/or programs. This expertise 

may include experience in the analysis, 

evaluation, and interpretation of 

federal/state health or regulatory policy; 

(3) Involvement in national, state, 

regional, tribal, and/or local efforts to 

improve the health status or outcomes 

among racial and ethnic minority 

populations; 

(4) Educational achievement, 

professional certification(s) in healthrelated fields (e.g., health professions, 

allied health, behavioral health, public 

health, health policy and health 

administration/management), and 

professional experience that will 

support the ability to give expert advice 

on issues related to improving minority 

health and eliminating racial and ethnic 

health disparities; and 

(5) Expertise in population level 

health data for racial and ethnic 

minority groups (e.g., survey, 

administrative, and/or clinical data). 

Desirable Qualifications: 

(1) Knowledge and experience in 

health care systems, cultural and 

linguistic competency, social 

determinants of health, evidence-based 

research, data collection (e.g., federal, 

state, tribal, or local data collection), or 

health promotion and disease 

prevention; and 

(2) Nationally recognized via peerreviewed publications, professional 

awards, advanced credentials, or 

involvement in national professional 

organizations. 

Requirements for Nomination 

Submission: Nominations should be 

typewritten (one nomination per 

nominator). Nomination package should 

include: (1) A letter of nomination that 

clearly states the name and affiliation of 

the nominee, the basis for the 

nomination (i.e., specific attributes 

which qualify the nominee for service in 

this capacity), and a statement from the 

nominee indicating a willingness to 

serve as a member of the Committee; (2) 

the nominee’s contact information, 

including name, mailing address, 

telephone number, and email address; 

(3) the nominee’s current curriculum 

vitae which should not exceed 10 pages; 

and (4) a summary of the nominee’s 

experience and qualification relative to 

the mandatory professional and 

technical criteria listed above. Federal 

employees should not be nominated for 

consideration of appointment to this 

Committee. 

Individuals selected for appointment 

to the Committee shall be invited to 

serve a four-year term. Committee 

members will receive a stipend for 

attending Committee meetings and 

conducting other business in the 

interest of the Committee, including per 

diem and reimbursement for travel 

expenses incurred. 

The Department makes every effort to 

ensure that the membership of an HHS 

federal advisory committee is fairly 

balanced in terms of points of view 

represented to support the committee’s 

function. Every effort is made to ensure 

a broad representation of individuals are 

considered for membership on HHS 

federal advisory committees, including 

considerations of geographic diversity, 

gender, racial and ethnic and minority 

groups, and people with disabilities. 

Appointment to this Committee shall be 

made without discrimination because of 

a person’s race, color, religion, sex 

(including pregnancy), national origin, 

age, disability, or genetic information. 

Nominations must state that the 

nominee is willing to serve as a member 

of ACMH and appears to have no 

conflict of interest that would preclude 

membership. An ethics review is 

conducted for each selected nominee; 

therefore, individuals selected for 

nomination will be required to provide 

detailed information concerning such 

matters as financial holdings, 

consultancies, and research grants or 

contracts to permit evaluation of 

possible sources of conflict of interest. 

Individuals selected to serve on the 

ACMH through the nomination process 

will be posted on the OMH website once 

selections have been made. 

Authority: 42 U.S.C. 300u–6, Section 

1707 of the Public Health Service Act, 

as amended. The Advisory Committee is 

governed by provisions of Public Law 

92–463, as amended (5 U.S.C. Appendix 

2), which sets forth standards for the 

formation and use of advisory 

committees. 

Dated: November 24, 2020. 

Samuel Wu, 

CAPT, U.S. Public Health Service, Designated 

Federal Officer, Advisory Committee on 

Minority Health. 

[FR Doc. 2020–26641 Filed 12–3–20; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Emergency Awards: Rapid 

Investigation of Severe Acute Respiratory 

Syndrome Coronavirus 2 (SARS-CoV–2) and 

Coronavirus Disease 2019 (COVID–19). 

Date: December 28–29, 2020. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E70, 

Rockville, MD 20892, (Virtual Meeting). 

Contact Person: Mohammed S. Aiyegbo, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E70, 

Rockville, MD 20852, (301) 761–7106, 

mohammed.aiyegbo@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 1, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–26751 Filed 12–3–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.